Onderzoeksoutput per jaar
Onderzoeksoutput per jaar
Persoonlijk profiel
Speerpunten
Lydia Visser received a PhD from the University of Groningen, the Netherlands in 2000 on her thesis titled: ‘Antibodies against leucocyte common antigen (CD45)-applications in immunomodulation’. She subsequently held a post-doctoral position at the Robards Research Institute of the University of Western Ontario in London (Ontario, Canada) on a project on the mechanism of anti-CD45RB tolerance induction. She is currently working at the department of Pathology and Medical Biology of the University Medical center Groningen as a scientist. She is as a PI part of the SALL. Her research is mainly focussed on the immunology of lymphoma and consists of interactions of tumor cells with the micro environment and signalling pathways in Hodgkin lymphoma and non-Hodgkin lymphomas.
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Onderzoeksoutput
-
Novel inhibitors of aspartate transcarbamoylase (atcase) and compositions, methods and uses related thereto
Groves, M. R., Wang, C., Lunev, S., Zhang, B., Dömling, A. S. S. & Visser, A., 8-jun.-2023, Octrooi Nr. WO2023101556, 2-dec.-2022, Prioriteitsdatum 2-dec.-2021Onderzoeksoutput
Open AccessBestand3 Downloads (Pure) -
Toxic Determination of Cry11 Mutated Proteins Obtained Using Rational Design and Its Computational Analysis
Suárez-Barrera, M. O., Herrera-Pineda, D. F., Rondón-Villarreal, P., Pinzón-Reyes, E. H., Ochoa, R., Visser, L. & Rueda-Forero, N. J., 22-mei-2023, In: International Journal of Molecular Sciences. 24, 10, 13 blz., 9079.Onderzoeksoutput › Academic › peer review
Open AccessBestand3 Downloads (Pure) -
A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma
Johnston, R. L., Mottok, A., Chan, F. C., Jiang, A., Diepstra, A., Visser, L., Telenius, A., Gascoyne, R. D., Friedman, D. L., Schwartz, C. L., Kelly, K. M., Scott, D. W., Horton, T. M. & Steidl, C., 10-feb.-2022, In: Blood. 139, 6, blz. 889-893 5 blz.Onderzoeksoutput › Academic › peer review
Open AccessBestand7 Citaten (Scopus)25 Downloads (Pure) -
Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro
Malenge, M. M., Maaland, A. F., Repetto-Llamazares, A., Middleton, B., Nijland, M., Visser, L., Patzke, S., Heyerdahl, H., Kolstad, A., Stokke, T., Ree, A. H. & Dahle, J., 29-apr.-2022, In: PLoS ONE. 17, 4, 22 blz., e0267543.Onderzoeksoutput › Academic › peer review
Open AccessBestand1 Citaat (Scopus)24 Downloads (Pure) -
CD4+ T cells in classical Hodgkin lymphoma express exhaustion associated transcription factors TOX and TOX2: Characterizing CD4+ T cells in Hodgkin lymphoma
Veldman, J., Placa, J. R., Chong, L., Terpstra, M. M., Mastik, M., van Kempen, L. C., Kok, K., Aoki, T., Steidl, C., van den Berg, A., Visser, L. & Diepstra, A., 31-dec.-2022, In: OncoImmunology. 11, 1, 11 blz., 2033433.Onderzoeksoutput › Academic › peer review
Open AccessBestand4 Citaten (Scopus)81 Downloads (Pure)
Activiteiten
- 1 Examination, teaching and supervision external institution
-
Examiner
Lydia Visser (Examiner)
14-feb.-2018Activiteit: Examination, teaching and supervision external institution › Academic
Datasets
-
Supplementary Material for: MicroRNA High Throughput Loss-of-Function Screening Reveals an Oncogenic Role for miR-21-5p in Hodgkin Lymphoma
Niu, F. (Contributor), Yuan, Y. (Contributor), Sarkis Azkanaz, M. (Contributor), Diepstra, A. (Contributor), Bystrykh, L. (Contributor), Visser, L. (Contributor), Dzikiewicz-Krawczyk, A. (Contributor), Osinga, J. (Contributor), Rutgers, B. (Contributor), Kok, K. (Contributor), Koerts, J. (Contributor), Terpstra, M. (Contributor), Kluiver, J. (Contributor), van den Berg, A. (Contributor), Nolte, I. (Contributor) & de Jong, D. (Contributor), figshare Academic Research System, 5-sep.-2018
DOI: 10.6084/m9.figshare.7047695.v1
Dataset